Barbara McLaughlin

Title: Barbara McLaughlin: Innovator in Blood Sample Processing

Introduction

Barbara McLaughlin is a notable inventor based in Ramona, California. She has made significant contributions to the field of blood sample processing, particularly with her innovative methods for removing red blood cells from whole blood samples. Her work has implications for various medical and research applications.

Latest Patents

Barbara McLaughlin holds a patent for a method to remove red blood cells from whole blood samples. This method involves contacting the whole blood sample with a solution containing an acid selected from a group that includes acetic acid, citric acid, ascorbic acid, lactic acid, maleic acid, malic acid, and malonic acid. The agglutinated red blood cells are then removed from the resultant suspension through procedures such as filtration, centrifugation, or decantation, resulting in an essentially red blood cell-free serum or plasma sample. This patent showcases her innovative approach to improving blood sample analysis.

Career Highlights

Barbara McLaughlin is associated with Quidel Corporation, where she applies her expertise in blood sample processing. Her work at Quidel Corporation has allowed her to contribute to advancements in medical diagnostics and research methodologies.

Collaborations

Some of her notable coworkers include Theodore T. Sand and William P. Kolb. Their collaboration has likely fostered an environment of innovation and shared knowledge within the company.

Conclusion

Barbara McLaughlin's contributions to the field of blood sample processing highlight her role as an innovator in medical technology. Her patented method for removing red blood cells from whole blood samples is a testament to her expertise and dedication to improving healthcare solutions.